Influenza affects approximately 1 billion individuals each year resulting in between 290,000
and 650,000 deaths. Young children and immunocompromised individuals are at a …

Influenza viruses cause annual epidemics and occasional pandemics that have claimed the
lives of millions. The emergence of new strains will continue to pose challenges to public …

These clinical practice guidelines are an update of the guidelines published by the
Infectious Diseases Society of America (IDSA) in 2009, prior to the 2009 H1N1 influenza …

This report updates previous recommendations by CDC's Advisory Committee on
Immunization Practices (ACIP) regarding the use of antiviral agents for the prevention and …

Please cite this paper as: McKimm‐Breschkin (2012) Influenza neuraminidase inhibitors:
Antiviral action and mechanisms of resistance. Influenza and Other Respiratory Viruses 7 …

In addition to immunization programs, antiviral agents can play a major role for the control of
seasonal influenza epidemics and may also provide prophylactic and therapeutic benefits …

Guidelines for the treatment of persons with influenza virus infection were prepared by an
Expert Panel of the Infectious Diseases Society of America. The evidence-based guidelines …

Background The goal of this study was to characterize viral loads and factors affecting viral
clearance in persons with severe influenza Methods This was a 1-year prospective …

These updated guidelines from the Infectious Diseases Community of Practice of the
American Society of Transplantation review the diagnosis, prevention, and management of …

Introduction. Medical advances have led to an increase in the world's population of
immunosuppressed individuals. The most severely immunocompromised patients are those …